[Federal Register: February 3, 2003 (Volume 68, Number 22)]
[Notices]               
[Page 5297]
From the Federal Register Online via GPO Access [wais.access.gpo.gov]
[DOCID:fr03fe03-59]                         


-----------------------------------------------------------------------


DEPARTMENT OF HEALTH AND HUMAN SERVICES


Food and Drug Administration


 
Food Advisory Committee; Notice of Meeting


AGENCY: Food and Drug Administration, HHS.


ACTION: Notice.


-----------------------------------------------------------------------


    This notice announces a forthcoming meeting of a public advisory 
committee of the Food and Drug Administration (FDA). The meeting will 
be open to the public.
    Name of Committee: Food Advisory Committee.
    General Function of the Committee: To provide advice and 
recommendations to the agency on FDA's regulatory issues.
    Date and Time: The meeting will be held on Monday, February 24, 
2003, from 8:30 a.m. to 5 p.m., and Tuesday, February 25, 2003, from 
8:30 a.m. to 5 p.m.
    Location: Sheraton College Park Hotel, Salons A, B, and C, 4095 
Powder Mill Rd., Beltsville, MD 20705, 301-937-4422.
    Contact Person: Sylvia M. Smith, Center for Food Safety and Applied 
Nutrition (HFS-006), Food and Drug Administration, 5100 Paint Branch 
Pkwy., College Park, MD 20740, 301-436-2397, or FDA Advisory Committee 
Information Line, 1-800-741-8138 (301-443-0572 in the Washington, DC 
area), code 10564. Please call the Information Line for up-to-date 
information on this meeting.
    Agenda: On February 24 and 25, 2003, the committee will meet to 
discuss FDA's action plan for addressing the issue of acrylamide in 
food and to discuss the findings and recommendations from the 
Contaminants and Natural Toxicants Subcommittee of the Food Advisory 
Committee.
    Procedure: Interested persons may present data, information, or 
views, orally or in writing, on issues pending before the committee. 
Written submissions may be made to the contact person by February 10, 
2003. Oral presentations from the public will be scheduled between 
approximately 4 p.m. and 5 p.m. on February 24, 2003. Time allotted for 
each presentation may be limited. Those desiring to make formal oral 
presentations should notify the contact person on or before February 
10, 2003, and submit a brief statement of the general nature of the 
evidence or arguments they wish to present, the names and addresses of 
proposed participants, and an indication of the approximate time 
requested to make their presentation.
    Persons attending FDA's advisory committee meetings are advised 
that the agency is not responsible for providing access to electrical 
outlets.
    FDA welcomes the attendance of the public at its advisory committee 
meetings and will make every effort to accommodate persons with 
physical disabilities or special needs. If you require special 
accommodations due to a disability, please contact Sylvia Smith at 
least 7 days in advance of the meeting.
    Notice of this meeting is given under the Federal Advisory 
Committee Act (5 U.S.C. app. 2).


    Dated: January 24, 2003.
William K. Hubbard,
Associate Commissioner for Policy and Planning.
[FR Doc. 03-2457 Filed 1-31-03; 8:45 am]

BILLING CODE 4160-01-S